Artelo Biosciences, Inc.
  • About
    • About Artelo
    • Management
    • Board of Directors
    • Scientific Advisors
    • Contact
  • Pipeline
    • Overview
    • ART27.13
    • ART26.12
    • ART12.11
  • Science
    • Overview
    • Publications
  • Investors
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Email Alerts
  • Media
  • Menu Menu
  • Twitter
  • LinkedIn
  • Facebook

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Media
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Email Alerts
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Media
Mar 09, 2021 8:30am EST

Artelo Biosciences Appoints Finance and Healthcare Industry Executive Tamara A. Seymour to Board of Directors

Mar 02, 2021 8:30am EST

Artelo Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference on March 9th

Feb 17, 2021 8:30am EST

Artelo Biosciences Announces Positive Pre-Clinical Data Associated with Proprietary CBD Cocrystal

Feb 16, 2021 8:30am EST

Artelo Biosciences Announces Appointment of Andrew Yates, Ph.D. as Senior Vice President and Chief Scientific Officer

Feb 08, 2021 8:30am EST

Artelo Biosciences Receives $3.0 Million in Net Proceeds from Exercise of Warrants

Feb 02, 2021 8:30am EST

Artelo Biosciences Announces Research Collaboration with Trinity College Dublin to Investigate ART27.13 for the Treatment of Cancer Cachexia

Jan 29, 2021 4:05pm EST

Artelo Biosciences to Present at the LSX World Congress Virtual Conference

Jan 14, 2021 8:30am EST

Artelo Biosciences Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Update

Jan 05, 2021 8:30am EST

Artelo Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference

Dec 09, 2020 8:30am EST

Artelo Biosciences Files Patent Application for New Formulation of ART27.13

  • Previous Pagearrow_back
  • Page 1…
  • …
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
©2025 - Artelo Biosciences, Inc.     info@artelobio.com    |     Terms of Use    |     Privacy Policy
  • Twitter
  • LinkedIn
  • Facebook